RO.CH

325.6

+0.74%↑

NOVN.CH

113.89

+0.11%↑

LONN.CH

493.4

+3.09%↑

SDZ.CH

65.52

+3.97%↑

STMN.CH

83.44

-4.2%↓

RO.CH

325.6

+0.74%↑

NOVN.CH

113.89

+0.11%↑

LONN.CH

493.4

+3.09%↑

SDZ.CH

65.52

+3.97%↑

STMN.CH

83.44

-4.2%↓

RO.CH

325.6

+0.74%↑

NOVN.CH

113.89

+0.11%↑

LONN.CH

493.4

+3.09%↑

SDZ.CH

65.52

+3.97%↑

STMN.CH

83.44

-4.2%↓

RO.CH

325.6

+0.74%↑

NOVN.CH

113.89

+0.11%↑

LONN.CH

493.4

+3.09%↑

SDZ.CH

65.52

+3.97%↑

STMN.CH

83.44

-4.2%↓

RO.CH

325.6

+0.74%↑

NOVN.CH

113.89

+0.11%↑

LONN.CH

493.4

+3.09%↑

SDZ.CH

65.52

+3.97%↑

STMN.CH

83.44

-4.2%↓

Search

Sonova Holding AG

Geschlossen

BrancheGesundheitswesen

171.2 0.41

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

171

Max

171.5

Schlüsselkennzahlen

By Trading Economics

Einkommen

189M

Verkäufe

1.8B

KGV

Branchendurchschnitt

19.989

67.147

EPS

3.16

Dividendenrendite

2.51

Gewinnspanne

10.389

Angestellte

18,035

EBITDA

382M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+17.06% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.51%

2.36%

Nächstes Ergebnis

18. Mai 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

10B

Vorheriger Eröffnungskurs

170.79

Vorheriger Schlusskurs

171.2

Nachrichtenstimmung

By Acuity

50%

50%

176 / 347 Ranking in Healthcare

Sonova Holding AG Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

25. Sept. 2025, 13:05 UTC

Wichtige Markttreiber

European Med-Tech Stocks Fall After U.S. Opens Import Probe

Peer-Vergleich

Kursveränderung

Sonova Holding AG Prognose

Kursziel

By TipRanks

17.06% Vorteil

12-Monats-Prognose

Durchschnitt 200.4 CHF  17.06%

Hoch 256 CHF

Tief 155 CHF

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Sonova Holding AG – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

10 ratings

3

Buy

4

Halten

3

Sell

Stimmung

By Acuity

176 / 347 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Sonova Holding AG

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. The company was founded in 1947 and is headquartered in Stäfa, Switzerland.
help-icon Live chat